Expert Opinion on Emerging Drugs

Papers
(The H4-Index of Expert Opinion on Emerging Drugs is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia28
A review of phase II and III drugs for the treatment and management of endometriosis28
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder28
New drugs targeting calcitonin gene-related peptide for the management of migraines21
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review19
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials19
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?19
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials18
Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?17
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape16
Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials15
Emerging biological treatments for asthma12
Emerging medicines to improve the basic defect in cystic fibrosis12
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia12
Emerging injectable therapies for osteoarthritis12
0.016102075576782